MicroSectors FANG+ 3x Leveraged ETNs due February 17, 2045 financials
$34.19−4.28%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Oct 31 | Q4 '24 Oct 31 | Q4 '23 Oct 31 | Q4 '22 Oct 31 | Q4 '21 Oct 31 | Q4 '20 Oct 31 | Q4 '19 Oct 31 | Q4 '18 Oct 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — | — | — |
| Diluted shares | 36.2M | 36.4M | 35.5M | 3.3M | 3.2M | 3.2M | 3.2M | 3.2M |
Balance sheet
| Period end | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $48.02B | $46.72B | $56.16B | $64.25B | $75.31B | $43.08B |
| Short-term investments | $395.47B | $367.03B | $316.96B | $288.08B | $281.46B | $266.51B |
| Total debt | $42.74B | $34.84B | $25.45B | $25.87B | $26.15B | $26.49B |
| Total assets | $1.05T | $1.01T | $970.66B | $836.78B | $798.00B | $712.28B |
| Total liabilities | $988.22B | $951.17B | $915.81B | $784.60B | $751.55B | $669.82B |
| Shareholders' equity | $62.69B | $60.49B | $54.85B | $52.18B | $46.45B | $42.46B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology